Americans spent $71 billion on GLP-1 drugs in 2023
Spending on Ozempic, Wegovy and other similar prescriptions soared 500 percent in five years, according to a research letter.
Uncategorized
Inside a neuroscientist’s quest to cure coma
The study of consciousness is a field crowded with scientists, philosophers, and gurus. But neuroscientist Daniel Toker is focused on its shadow twin: unconsciousness. His path to this research began with a tragedy — one he witnessed firsthand. While at a music festival, a young concertgoer near Toker dove headfirst into a shallow lake. He … Read more
Spending on GLP-1 Drugs Has Skyrocketed
It’s not just talk. Americans’ spending on GLP-1 drugs including Ozempic and Wegovy has skyrocketed in the last five years. Spending hit $71.7 billion in 2023 for a 500% increase from $13.7 billion in 2018, according to a research letter published this month in JAMA Network Open , described…
Why GLP-1 Weight-Loss Drugs Are Hard to Make into Pills
Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and accessibility. What’s keeping the pills from taking off?
The Quest to Build a Perfect Protein Bar
2025-04-21T10:00:00.000Z Save this storySave this story Save this storySave this story In the past seventy-five years in America, the nutritional bar has gone from niche to mainstream. In the fifties, Bob Hoffman, of York, Pennsylvania, known as “the father of weightlifting,” and an early manufacturer of barbells, hawked a product called Hi-Proteen Honey Fudge. Made … Read more
What Are Health Systems’ Strategic Priorities in 2025?
The healthcare investor conference MedCity INVEST, scheduled for May 20-21 at the Willis Tower in Chicago, will spotlight a wide range of topics from GLP-1 drug coverage to investment trends and more. Register today! The post What Are Health Systems’ Strategic Priorities in 2025? appeared first on MedCity News.
Tools for Overcoming Substance & Behavioral Addictions | Ryan Soave
My guest is Ryan Soave, LMHC, a leading expert in addiction recovery with extensive experience helping people heal from all types of substance and behavioral dependencies. We discuss actionable tools for breaking out of the addictive cycle and staying free of obsessions and compulsions. We also examine the relationship between trauma and addiction. We explore … Read more
Did Eli Lilly Just Say Checkmate to Novo Nordisk?
Novo Nordisk (NYSE: NVO) has seen revenue soar in recent years thanks to two drugs that have helped people around the world lose weight. The molecule is semaglutide, and it’s sold under the name Ozempic for type 2 diabetes and Wegovy for weight loss — but doctors have prescribed either for weight management. And this … Read more
Human Experiments on GLP-1 Pill Looking Extremely Promising
Forget injections. A new drug promises to be just as effective as Ozempic — but is taken as a daily pill. Called orforglipron, the results of a new clinical trial announced Thursday by manufacturer Eli Lilly suggest that the pill could be a breakthrough in a class of drugs called GLP-1 agonists, which have become … Read more